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Abstract
Background: Extracorporeal membrane oxygenation (ECMO) is a useful treatment for refractory out-of-hospital
cardiac arrest (OHCA). However, little is known about the predictors of survival and neurologic outcome after
ECMO. We analyzed our institution’s experience with ECMO for refractory OHCA and evaluated the predictors of
survival and neurologic outcome after ECMO.
Methods: This was a retrospective review of the medical records of 23 patients who were treated with ECMO due to
OHCA that was unresponsive to conventional cardiopulmonary resuscitation, between January 2009 and January 2014.
Results: Our ECMO team was activated within 10 min for refractory OHCA, and the 30-day survival rate was 43.5 %. In
a multivariate analysis that evaluated independent factors contributing to mortality, urine output ≤ 0.5 mL · kg−1 · h−1
(defined as oliguria) during the 24 h after ECMO was statistically significant (OR, 32.271; 95 % CI, 1.379–755.282; p = 0.031).
Just after ECMO implantation, 6 of the 9 patients (66.7 %) who had normal findings on brain computed tomography
(CT) survived with a cerebral performance category (CPC) of grade 1. However, only 3 of the 11 patients (27 %) who had
evidence of hypoxic brain damage on initial brain CT survived (their CPC grade was 4).
Conclusions: Based on our findings, the survival rate can be improved by rapid implantation of ECMO, and oliguria seen
during the first 24 h after ECMO may be an independent predictor of mortality. Furthermore, findings on brain CT just
after ECMO and subsequent images may represent an important predictor for neurologic outcome after ECMO.
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Background
Out-of-hospital cardiac arrest (OHCA) has a poor prog-
nosis, with survival rates between 4 and 39.3 % [1–5].
Cardiac arrest patients can tolerate only a short period of
circulatory disturbance and the chances of survival de-
crease rapidly when cardiopulmonary resuscitation (CPR)
lasts over 15–30 min [6, 7]. Furthermore, refractory car-
diac arrest, defined as persistent circulatory failure despite
more than 30 min of appropriate CPR, is usually fatal in
the intensive care unit [8].
Extracorporeal membrane oxygenation (ECMO) is an
aggressive and invasive type of extracorporeal life support
(ECLS) that has been suggested for refractory cardiac arrest
[9]. ECMO can be performed during resuscitation, and it pro-
vides sufficient perfusion of vital organs during the treatment
of cardiac arrest and provides injured myocardium with the
chance to recover [10]. Several recent studies have shown fa-
vorable outcomes regarding survival after in-hospital cardiac
arrest and in OHCA patients receiving ECLS [1, 4, 5, 11].
However, few reports have analyzed its effectiveness in terms
of neurological outcomes inOHCApatients.
The present study retrospectively evaluated our institu-
tion’s results with ECMO in adult patients with refractory
OHCA. This study focused on survival rate, neurological




This study received approval from our institutional review
board (IRB No. 2012–93) Hallym University Medical
Center, Chuncheon. Informed consent was waived due to
its retrospective study design. Of 119 patients who under-
went ECMO between January 2009 and January 2014, this
study retrospectively reviewed the records of 23 patients
who had cardiac arrest outside of the hospital but did not
achieve return of spontaneous circulation (ROSC) within
10 min of CPR, or patients with recurrent arrests despite
ROSC for over 20 min within 2 h after arriving at the hos-
pital (Fig. 1). In addition, patients with ongoing intracra-
nial hemorrhage or terminal malignancy, those who
required constant support, and those who underwent un-
witnessed cardiac arrest were excluded from the study. All
patients with OHCA were treated by the emergency med-
ical technician (EMT), who trained for basic life sup-
port (BLS). At the scene, EMT performed 30 chest
compression and 2 bag valve mask ventilation. Espe-
cially, automated external defibrillator was applied for a
patient with shockable rhythm. After 10 cycles of BLS
at the scene, the patient was transported to our emer-
gency department by ambulance, thereafter emergency
medical staff performed advanced life support.
After arriving at the hospital, the subjects received
CPR under emergency medicine staff supervision. If
ROSC was not achieved within 10 min of beginning
CPR, the ECMO team reassessed each subject’s status. If
the status indicated ECMO, the ECMO was immediately
implanted in the catheterization laboratory during cardiac
compressions.
ECMO equipment and management
Three types of centrifugal pumps were used to deliver
the ECMO: the Capiox Emergency Bypass System®
(Terumo, Inc., Tokyo, Japan) and the Bio-pump®
(Medtronic Inc., Minneapolis, MN, USA) were used
from January 2009 to May 2010; from June 2010 onward,
a Centrifugal Rotaflow pump® (Maquet Inc., Hirrlingen,
Germany) was used in most patients. Depending on pa-
tient size, we used 17–21 Fr arterial cannulae (DLP®, Bio-
Medicus, Medtronic Inc.; or RMI®, Edwards Lifesciences
Fig. 1 Flow diagram of the study population and outcome ECMO, extracorporeal membrane oxygenation; OHCA, out-of-hospital; ECPR, extracorporeal
cardiopulmonary resuscitation; VA, venoarterial; VV, venovenous
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LLC, Irvine, CA, USA) and 17–28 Fr venous cannulae
(DLP®, Bio-Medicus, Medtronic Inc.; or RMI®, Edwards
Lifesciences LLC).
ECMO was performed in the Catheterization Lab with
an injection of heparin at 50–80 u/kg, followed by fluoros-
copy guided cannulation of the femoral artery and vein via
the Seldinger method during cardiac compression.
Our center used an anticoagulant, nafamostat mesilate
(SK Chemicals Life Science Biz., Seoul, Korea Licensed
by Torii Pharmaceutical Co. Ltd, Tokyo, Japan) at 0.4–
1.5 mg · kg−1 · h−1 and maintained the partial thrombo-
plastin time at 60–80 s to decrease the bleeding risk caused
by ECMO. Patients who did not have a high bleeding risk
were maintained with heparin injections of 300–1,400 u/h
to achieve an activated clotting time of 140–180 s.
After ECMO, patients in whom coronary artery disease
was suspected underwent coronary angiography and re-
ceived percutaneous coronary intervention. Intra-aortic
balloon pump was taken in patients who had no improve-
ment in cardiogenic shock despite high doses of inotropics
before ECMO, or patients who had a mean blood pres-
sure below 40 mmHg despite the use of inotropics after
ECMO. Brain computed tomography (CT) was checked
after ECMO began and all procedures were performed
in the catheterization laboratory when the Glasgow coma
score (GCS) was below 7 (eyes open: to pain, motor: local-
ized pain, verbal: intubated state) [12]. Then CT and mag-
netic resonance imaging (MRI) of the brain were then
performed and the CT was checked in cases of 1) GCS
below 7 during the 72 h after ECMO, or 2) change in
pupil size with an absent pupil light reflex in patients who
recovered the reflex. MRI was used to evaluate brain func-
tion of surviving patients before discharge. The criteria for
the hypoxic brain damage in the brain CT was 1) Diffuse
mass effect with effacement of the cerebral sulci and of
the brainstem cisterns 2) Global decrease in the cortical
gray-matter density from edema, causing loss of the nor-
mal gray-white matter differentiation 3) Low density le-
sions of the basal ganglia bilaterally 4) Decreased gray
matter density in the watershed distributions bilaterally.
Especially, gray/white matter ratio was an en early pre-
dictor for hypoxic brain damage [13, 14]. Hypothermia
therapy was performed when the GCS was below 9 (eyes
open: to speech, motor: obeys, verbal: intubated state)
after arrival to the intensive care unit. This was provided
using a heater unit (Maquet Inc., Hirrlingen, Germany)
by maintaining the body temperature at 33–34 °C for
24 h without sedatives. If the GCS rose above 9, the pa-
tient’s body temperature was raised 0.5 °C per hour
using sedatives.
The ECMO flow was maintained at 3.0–4.0 L/min, while
the mean blood pressure was sustained at >60 mmHg. If
necessary, norepinephrine or dopamine was also adminis-
tered. For patients who received percutaneous coronary
intervention (PCI), clopidogrel 300 mg and aspirin 250 mg
were administered on the date of the procedure; from the
second day onward, the doses were reduced to 75 mg and
100–200 mg, respectively. Care was taken to maintain the
hematocrit level and platelet count at 30–35 % and
50,000–80,000/μL, respectively, and a transfusion was
given when these values decreased. A 2D-echo was done
daily to check for thrombi in the heart chambers and to
ensure improvement of wall motion. ECMO was re-
moved when the ejection fraction exceeded 30 % at the
ECMO flow of 1 L/min on echocardiography. Success-
ful ECMO weaning and survival were defined as cases
of survival > 24 h after the removal of ECMO and > 30 d
after the ECMO run.
Statistical analysis
Statistical analyses were performed using the IBM SPSS
Statistics program (ver. 21; IBM Co., NY, USA); continu-
ous and categorical variables were analyzed using the
Mann Whitney U-test and the Pearson chi square test
or Fisher’s exact test, respectively. The univariate and
multivariate stepwise logistic regression analysis model
was used to identify independent mortality-related factors.
Values of p < 0.05 were considered statistically significant.
Survival outcomes of the patients who survived OHCA
were analyzed using the Kaplan-Meier survival method.
Results
Totally 36 patients with OHCA were transported to
emergency room. Among these patients, 13 patients had ar-
chived ROSC after conventional CPR. The four drowning
patients received venovenous ECMO due to refractory hyp-
oxia after ROSC. These patients were 30 day survivors and
discharged with CPC 1 score. Nine patients received
venoarternial ECMO due to shock after ROSC. Only one
patient was a 30 day survivor (Fig. 1). In the case of E-CPR,
AMI (15 cases) was the most common cause, followed by
anaphylaxis (bee sting 2 cases, drug allergy 1 case), ven-
tricular fibrillation (2 cases), commotion cordis (assault
1 case), hypothermia (1 case, falling in a river for 34 minutes
in the winter) and AAA rupture (1 case).
The clinical characteristics of the survival group and
mortality group are compared in Table 1. The patients’
age, gender, body mass index, pre-ECMO sequential organ
failure assessment, simplified acute physiology score 2
score, the use of an intra-aortic balloon pump (IABP),
PCI, and continuous renal replacement therapy showed
no statistical significance, but PaO2 in the pre-ECMO la-
boratory findings was statistically significant (p = 0.009).
Most patients (63 %) experienced cardiac arrest in
public, and were given CPR after an average of 1 min.
Fourteen patients (61 %) were given CPR by a bystander.
The median time from collapse to arrival at hospital was
22 min, and 87 % of the patients showed a rhythm of Vf
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or VT at arrival. Only three patients achieved ROSC
after CPR at the hospital and they were maintained for
over 20 min, but eventually went through ECMO be-
cause of recurrent cardiac arrest. The median door to
ECMO time was 55 min (p = 0.030). A positive pupil light
reflex (p = 0.007), vasoactive inotropic score after 6 h of
ECMO (p = 0.030), 24 h urine output (<0.5 mL · kg−1 · h−1)
(p < 0.001) after admission, and ECMO maintenance time
(p = 0.008) showed statistical significance (Table 2) [15].
CT of the brain was performed just after ECMO implant-
ation in 20/23 patients (87 %). Three patients were ex-
cluded, because one who survived had a GCS of 9 and the
other two patients, who died, could not be maintained on
ECMO flow due to abdominal aortic rupture and massive
Table 1 Comparison of patients’ clinical characteristics between non-survivors and survivors
All Non-survivors Survivors p
N = 23 N = 13 N = 10
Age, years 55 (40, 68) 57 (46.5, 72.5) 52 (35.5, 61) 0.208
Gender, male (%) 20 10 10 0.229
BMI 22.8 (21.9, 26.1) 22.9 (21.2, 28.1) 22.6 (22.4, 24.1) 0.648
Past medical history
Hypertension 12 8 4 0.414
Diabetes 12 8 4 0.414
Previous PCI 4 3 1 0.604
Cerebral vascular accident 2 1 1 1.000
Causes of cardiac arrest 0.329
AMI 15 8 7
Anaphylactic shock 3 3 -
Arrhythmia 2 1 1
Commotio Cordis 1 - 1
Hypothermia 1 - 1
AAA rupture 1 1 -
Pre-ECMO laboratory findings
pH 7.01 (6.80, 7.08) 6.98 (6.80, 7.13) 7.02 (6.97, 7.04) 0.422
PaO2 33 (7, 54.5) 10 (6, 42) 51 (28, 70) 0.009a
PaCO2 69 (55.5, 97.5) 71 (64.5, 103) 61 (37.5, 88) 0.095
CK-MB 6.1 (2.2, 15.73) 4.4 (2.0, 24.2) 6.1 (2.5, 7.6) 0.976
Troponin-I 0.17 (0.06, 3.25) 0.17 (0.07, 6.15) 0.17 (0.05, 1.03) 0.522
BUN 14.5 (11.3, 20.1) 14.5 (12.1, 21.0) 16.0 (9.2, 20.5) 0.927
Creatinine 1.2 (1.1, 1.4) 1.3 (0.8, 1.4) 1.2 (1.1, 1.5) 0.784
Total bilirubin 0.78 (0.59, 1.13) 0.75 (0.57, 1.11) 0.92 (0.7, 1.21) 0.410
Lactate 9.7 (7.7, 13.2) 10.4 (8.4, 13.9) 9.0 (6.9, 11.6) 0.284
Pre-ECMO
SOFA score 14 (13, 16) 14 (13.5, 16) 14 (12.8, 15.3) 0.446
SAPS 2 score 87 (80, 97) 90 (83.5, 99.5) 82.5 (75, 91.3) 0.077
PCI 15 (65.2 %) 9 (69.2 %) 6 (60 %) 0.646
IABP 0.604
Pre-ECMO 2 1 1
After-ECMO 2 2 -
CRRT 18 10 8 1.000
BMI body mass index, PCI percutaneous coronary intervention, AAA abdominal aortic aneurysm, BUN blood urea nitrogen, SOFA, sequential organ failure
assessment, SAPS 2 simplified acute physiology score, IABP intra-aortic balloon pump, CRRT continuous renal replacement therapy, IQR continuous variables
expressed median
asignificant difference
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gastrointestinal bleeding, respectively. On the initial brain
CT, 9 patients showed normal findings but 11 had evi-
dence of hypoxic brain damage. In the follow-up brain im-
ages, 3 surviving patients had normal findings, 3 had
evidence of mild hypoxic brain damage with a CPC grade
of 1, and 3 had evidence of hypoxic brain damage of CPC
grade 4 (Table 3). The complications related to CPR and
ECMO are shown in Table 4.
In a univariate analysis evaluating independent fac-
tors of mortality, the pre-ECMO PaO2 (odds ratio
[OR], 0.946; 95 % confidence interval [CI], 0.901–0.993;
p = 0.025), and a 24 h urine output of ≤0.5 mL · kg−1 · h−1
(OR, 20.250; 95 % CI, 11.878–218.390; p = 0.013) showed
statistical significance. However, in multivariate ana-
lysis, only the 24 h urine output of ≤ 0.5 mL · kg−1 · h−1
(OR, 32.271; 95 % CI, 1.379–755.282; p = 0.031) showed
statistical significance (Table 5). Of the 10 survivors, 3 pa-
tients died on the 38th, 50th, and 94th day in the hospital,
respectively, and of the 7 patients who were discharged, 6
had a CPC of grade 1 and 1 had a CPC of grade 4, all of
Table 2 Comparison of CPR- and ECMO-related characteristics between non-survivors and survivors
All Non-survivors Survivors p
N = 23 N = 13 N = 10
Locations of victims 0.472
Public 15 10 5
Home 5 2 3
In-ambulance during transportation 2 1 1
Other hospital 1 - 1
Time of collapse to CPR start, min 1 (1, 5) 4 (1, 6) 1 (1, 1.75) 0.166
Bystander CPR 14 6 8 0.197
First monitored rhythm 0.685
Shockable 10 5 5
Non-shockable 13 8 5
Transport time from collapse to hospital, min 22 (15, 38) 22 (15, 51) 21 (13, 30) 0.910
EKG rhythm on arrival at ED 0.177
Vf/VT 20 12 8
PEA 2 - 2
Asystole 1 1 -
Collapse to ECMO time, min 84 (61, 101) 94 (72.5, 127) 64.5 (55.25, 89.75) 0.101
CPR time, min 62 (53, 86) 66 (58.5, 108) 57.5 (40.5, 73.75) 0.101
ROSC ≥ 20 min during CPR 3 2 1 1.000
Door to ECMO time, min 55 (41, 67) 62 (49, 71.5) 45 (32.5, 56.5) 0.030a
ROSB at ICU arrival 17 10 7 1.000
Pre-ECMO VIS 41.0 (16.4, 76.2) 63.5 (0, 93.8) 39.6 (31.7, 71.6) 0.832
Post-ECMO VIS; at 6 h on ICU arrival 7.6 (0, 22.6) 11.3 (3.4, 58.4) 0 (0, 7.8) 0.030a
24 h urine output (ml · kg−1 · h−1) 0.92 (0.03, 2.33) 0.1 (0–0.92) 2.39 (1.59, 3.86) <0.001a
Pupil diameter on arrival at ED, mm 6 (6, 7) 7 (6, 7) 6 (3.5, 7.25) 0.414
Pupil reflex positive after ECMO 15 6 10 0.007a
Hypothermia for 24 h 18 12 6 0.127




VIS (vasoactive inotropic score) = IS +milrinone dose (μg/kg/min) + 10000 × vasopressin dose (unit/kg/min) + 100 × norepinephrine dose (μg/kg/min),
IS (inotropic score) = dopamine dose (μg/kg/min) + dobutamine dose (μg/kg/min) + 100 × epinephrine dose (μg/kg/min)
CPR cardiopulmonary resuscitation, ECMO extracorporeal membrane oxygenation, ED emergency department, Vf ventricular fibrillation, VT ventricular tachycardia,
PEA pulseless electrical activity, ROSC return of spontaneous circulation, ROSB return of spontaneous beat, ICU intensive care unit, CPC cerebral performance
category, IQR continuous variables expressed median
asignificant difference
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whom survived without any complications for an average
of 19 months (range, 1–57 months) (Fig. 2).
Discussion
Prolonged CPR is associated with poor outcomes, and
only a small percentage of patients return to their former
lives without complications [6–8, 16, 17]. In order to
overcome this limitation, E-CPR was considered as an al-
ternative treatment for cardiopulmonary arrest. In animal
model, Trummer et al. demonstrated that E-PCR showed
better outcome than conventional CPR. In recent clinical
studies, E-CPR also showed the same results. In previous
studies, alternative CPR using ECMO was reported to be
effective for patients in whom return of spontaneous cir-
culation could not be achieved by conventional CPR [1,
10, 18–20]. In OHCA patients, however, the survival rates
reported in the literature are relatively low at 4–28.3 %
despite using ECLS (Table 6) [1–4]. The current guide-
lines for CPR recommend that ECLS be considered in
CPR when the patient’s time without blood flow is short
[9], and a recent study reported that the 30-day survival
rate of refractory OHCA patients was 39.3 % when ECLS
support is established within the first 30 min after admis-
sion (Table 6) [5].
Our study found a 30-day survival rate of 43.5 %,
which was superior to that of previous studies of 55 min
(median) for implanting ECMO after arrival at the emer-
gency department. Our better survival rate may have
been due to activation of the ECMO team within 10 min
for refractory cardiac arrest. Le Guen et al. [2] and Avalli
et al. [3] reported that ECLS was considered in the case
of absence of ROSC after 30 min of CPR. Kagawa et al. [1]
and Chen et al. [10] suggested that it be considered within
20 min and after 10 min without ROSC, respectively. In
the present study, all patients were rapidly and accurately
provided ECMO during CPR in the catheterization labora-
tory near the emergency department; as a result, the inci-
dence of bleeding at the cannulation site was lower than
in other studies (Table 6) [1, 3]. However, 3/23 patients
(13 %) had bleeding at the cannulation site and all of
them died. Nagao et al. [21] reported that bleeding or
hematoma at the cannulation site complicates patient
management, negatively affecting the outcome.
In the present study, multivariate logistic regression ana-
lysis identified a 24 h urine output (UO) of ≤ 0.5 mL · kg-1 ·
h-1 as an independent risk factor of 30-day mortality.
Zhang et al. and Prowle et al. reported that lower urine out-
put is associated with an increase of mortality in critically
ill patients. [22, 23] Thus, it is noteworthy that our patients
with oliguria in the first 24 h had a significantly different
mortality rate, suggesting that oliguria during the first 24 h
after ECMO may be a useful predictor of survival.
The neurologic outcome is a grave concern following
ECLS [1–4, 11, 24–27]. A potential limitation of a
wider use of ECLS in refractory cardiac arrest was the
fear that it might lead to severe neurological sequelae
in the patients, leading to costly resources and consid-
erable suffering for the patients and their families [28].
However, few studies have analyzed the predictors of
neurologic outcome after ECLS. Maekawa et al. [5] sug-
gested that pupil diameter on hospital arrival may be a












1 1 - 1.000
Pneumothorax 2 1 1 1.000
Chylothorax 1 - 1 0.435
Pulmonary hemorrhage 2 2 - 0.486
Hypoxic brain damage 14 11 3 0.001a
Cannula related complication
Cannula site bleeding,
≥ 2 units/d pRBC
transfusion
3 3 - 0.229
Leg ischemia d/t septic
emboli and right common
iliac artery obstruction
2 - 2 0.178
Acute renal failure 11 6 5 1.000
Ulcer bleeding 1 1 - 1.000
Pneumonia 15 5 10 0.003a
ICH d/t hypoxic brain
damage
4 4 - 0.104
Sore 4 - 4 0.024a
Sepsis 5 2 3 0.618
CPR cardiopulmonary resuscitation, d day, pRBC packed red blood cell,
ICH intracranial hemorrhage
asignificant difference
Table 3 Characteristics of brain images
Brain CT just
after ECMO
FU brain image Outcomes Total
Death Survival
N = 13 N = 10 N = 23
Hypoxic brain















ICH due to hypoxic
brain damage
2 - 2
Check (−) n = 3 Check (−) 2 1 3
CT computer tomography, ICH intracranial hemorrhage
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key predictor of neurologic outcome in patients who
received ECLS. However, we observed no difference in
survival rate depending on pupil diameter on arrival to
the emergency room. Instead, we observed that the
pupil reflex in all of the surviving patients who under-
went ECMO changed from negative to positive.
Interestingly, in this study, 20/23 patients had a brain
CT just after ECMO implantation. According to the re-
sults, 6 of the 9 patients (66.7 %) who had a normal CT
just after ECMO survived and 3 of them had a normal
follow-up CT. The other 3 showed minimal hypoxic
brain damage, but all were able to live a normal life.
However, only 3 of the 11 patients (27 %) who had hyp-
oxic brain damage on initial brain CT survived; their
CPC grade was 4. These results suggest that hypoxic
brain damage immediately following ECMO can result
in a poor neurologic outcome. Furthermore, all four pa-
tients who had intracranial hemorrage due to hypoxic
brain damage on follow up images died regardless of
the initial CT findings. Based on our results, CT of the
brain just after ECMO and follow-up brain images may
help to predict the neurologic outcome and survival.
However, further studies are necessary to fully validate
this finding.
Study limitation
Several limitations must be considered in the interpret-
ation of our results. First, the total number of enrolled
patients was very small. Owing to strict indication for
ECPR, the number of case of ECPR was inevitably small.
Due to the limitation in the statistical analysis, it is im-
portant not to make strong conclusions. Therefore, it is
imperative for a well- designed study with large sample
size to ensure the outcome and risk factor in ECPR.
Second, this was a study of a single institution with an
experienced ECMO team and a well-established system.
However, not all hospitals have the same type of team and
system. Thus, our results should be interpreted with cau-
tion, although we highlighted the importance of rapid and
accurate ECMO. Third, the study was not a randomized
controlled trial, but rather a retrospective analysis of our
experience with ECMO for refractory OHCA.
Table 5 Univariate analysis and multiple logistic regression analysis of predictors for mortality
Variables Univariate analysis Multivariate analysis
OR 95 % CI p OR 95 % CI p
Pre-ECMO PaO2 0.946 0.901–0.993 0.025a 0.936 0.873–1.005 0.068
24 h urine output ≤ 0.5 mL · kg−1 · h−1 20.250 1.878–218.390 0.013a 32.271 1.379–755.282 0.031a
ECMO extracorporeal membrane oxygenation, OR odds ratio, CI confidence interval.
asignificant difference
Fig. 2 Kaplan-Meier survival curve. All seven patients considered fit for discharge survived
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Conclusions
ECMO can be an appropriate therapeutic option in pa-
tients with refractory OHCA. On the basis of our findings,
the survival rate can be improved by mobilization of the
ECMO team within 10 min for refractory OHCA, and
rapid and accurate implantation of ECMO. Oliguria dur-
ing the first 24 h after ECMO may be an independent pre-
dictor of mortality. Furthermore, CT of the brain just after
ECMO and subsequent brain imaging may be important
predictors of neurologic outcome after ECMO.
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Table 6 Literature review of results of extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest, and our results
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Time interval from collapse to ECLS start,
min (IQR); 59(45–65).
Successful percutaneous cannulation (38/39; 97 %).
Complications after ECLS; cannula site bleeding
(23/39; 59 %), acute kidney injury (9/39; 23 %),
leg malperfusion (8/39; 21 %), pneumonia (7/39; 18 %),
sepsis (3/39; 8 %).




24 h survival rate after ECLS (17/42; 40 %).
48 h survival rate after ECLS (5/42; 12 %).
28 day survival rate after ECLS (2/42; 4 %).




Survival rate of patients with OHCA (1/18; 5 %)
lower than IHCA (11/24; 46 %).
Low flow time of OHCA (77 min) longer than
IHCA (55 min).
Cannulation failure: two in OHCA (2/18; 11 %)
In OHCA, complications ECMO; distal leg perfusion
(4/18; Haneya22%), femoral leg lesion (2/18; 11 %).
Haneya et al. 2012 [29] 26 Survival discharge
6 (23.1)
Forty patients (47 %) were successfully weaned
and 29 patients (34 %) survived to hospital discharge.
Maekawa et al. 2013 [5] 53 3 mon
15 (28.3)
CPC 1 or 2 at
3mon: 8 (15.1)
Survival rate at 3 months (15/53; 28.3 %)
Complications after ECLS; cannulation site
bleeding (17/52; 32.7 %),
cannulation site infection (4/52; 7.7 %).
Pupil diameter on hospital arrival may be associated
with the neurologic outcome.
Leick et al. 2013 [4] 28 11 (39.3) No check Door to ECLS implantation time < 30 min
→ significantly improved the 30 day survival
Complications after ECLS; bleeding (9/28; 32 %),
lower limb ischemia (1/28; 3.6 %).
Sakamoto et al. 2014 [30] 260 32 (12.3) ECPR 26 hospitals vs. non-ECPR 20 hospitals
CPC 1–2 at 1 months: 12.3 vs. 1.5 %
CPC 1–2 at 6 moths: 11.2 vs. 2.6 %
Stub et al. 2014 [31] 9 Survival discharge
3 (33.3)
CPC 1 or 2 at discharge
3 (33.3)
CHEER trial (11 with OHCA, 15 with IHCA)
CPC score 1: 14/26 (54 %)
collapse to initiation of ECMO: 56 min
Our results 23 30 day
10 (43.5)
CPC 1: 7 (30)
CPC 4: 3 (13)
Door to ECMO team activation time < 10 min
for refractory OHCA.
Rapid and accurate ECMO implantation in the
catheter laboratory.
Complications after ECLS; cannulation site bleeding
(3/23; 13 %).
Oliguria may be a predictor for mortality.
Brain CT just after ECMO and following brain
imaging may be a predictor for neurologic outcome.
n number of patients, CPC cerebral performance category, ECLS extracorporeal life support, GOS glasgow outcome scale, OHCA out-of-hospital cardiac arrest,
IHCA in-hospital cardiac arrest, ECMO extracorporeal membrane oxygenation, CT computed tomography
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